Marek Pawlicki

Statistics

Publications

Citations

9.2K

H-Index

Active since

1983

Affiliations

Bydgoszcz University of Science and Technology(Current)

AGH University of Krakow

Instytut Technik Telekomunikacyjnych i Informatycznych (Poland)

The Maria Sklodowska-Curie National Research Institute of Oncology

University of Warsaw

Marek Pawlicki is an author at Bydgoszcz University of Science and Technology specializing in engineering, information security, and computer science.

ORCID

Top concepts

EngineeringInformation SecurityComputer ScienceData ScienceMachine LearningInformation ForensicsMedicineOncologyRadiation OncologyData Mining

Publications per year

1983–2024

Publications

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis J. Slamon, W. Eiermann, Nicholas J. Robert et al. · New England Journal of Medicine · 2011 · 2.7K citations · Full text

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 950 citations · Full text

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 726 citations

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian et al. · Cancer · 2004 · 716 citations · Full text

1–5 of 57